Felicity Sartain is a chemist and holds a doctorate in biotechnology. Previously, she has worked at GlaxoSmithKline, where her research focussed upon the development of novel detection techniques to enhance the drug discovery process. Her PhD research at the University of Cambridge, on holographic sensor design and development was patented and subsequently, she went on to work for the spin-out company Smart Holograms. Here, she worked primarily in the R&D team but also assisted in product and process development. Her main project focus whilst at Smart Holograms was on the development of a continuous blood glucose monitor.
In addition to her role at BNC, Felicity is also working for the UK’s Nanotechnology Knowledge Transfer Network, where she is coordinating activities of the NanoRegen focus group.